Nicholas Lydon
for the development of a new therapeutic drug targeting cancer-specific molecules.
Affiliated at time of winning
Cambridge, United States
Recognition for work with lasting impact
for the development of a new therapeutic drug targeting cancer-specific molecules.
Cambridge, United States